|
|
||||||||
Ann Thorac Surg 2000;70:1577-1579
© 2000 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, General Hospital Klagenfurt, Klagenfurt, Austria
b Department of Anesthesiology, General Hospital Klagenfurt, Klagenfurt, Austria
c Institute for Laboratory Medicine, General Hospital Klagenfurt, Klagenfurt, Austria
Address reprint requests to Dr Wandschneider, Department of Cardiothoracic Surgery, General Hospital Klagenfurt, St. Veiter Strasse 47, A-9020 Klagenfurt, Austria
e-mail: wwand{at}netway.at
| Abstract |
|---|
|
|
|---|
Methods. S100, a protein specific for cerebral tissue, was used as a marker for cerebral impairment in 108 randomized patients undergoing coronary bypass operation: 67 patients (group A) were operated on with extracorporeal circulation and cardioplegic cardiac arrest, and 41 patients (group B) underwent off-pump beating heart revascularization. Both groups were similar regarding age, sex, ejection fraction, and number of anastomoses. S100 levels were measured from induction of anesthesia until 24 hours after the operation.
Results. Data collection was 100% complete. There was no in-hospital death. Nonfatal myocardial infarctions occurred in 2 patients in group A, and 1 patient in group B required resternotomy for bleeding. There was no neurologic deficit in either group. S100 levels increased only slightly in the off-pump patients (group B), whereas in group A there was a sharp rise in S100 concentration during extracorporeal circulation, only returning to baseline 6 hours after the end of the operation. Peak S100 levels were four times higher in group A than in group B (2.1 µg/L versus 0.5 µg/L; p < 001).
Conclusions. The results of our study suggest that perioperative cerebral impairment is reduced in cardiac operations without the use of extracorporeal circulation. Further large-scale studies are needed to show whether this result is reflected by fewer neurologic deficits.
| Introduction |
|---|
|
|
|---|
S100 is a calcium binding protein present in astroglial and microglial cells and is highly specific for the brain [6]. As it does not normally pass the blood-brain barrier its appearance in the serum is an indicator for cerebral damage [7, 8]. By means of a specific immunoassay (Sangtec 100, Byk-Sangtec Diagnostica, Dietzenbach, Germany) it is possible to measure serum levels of the isoenzyme S100b.
| Material and methods |
|---|
|
|
|---|
Group A (67 patients) underwent classic coronary bypass grafting using extracorporeal circulation and cardioplegic cardiac arrest. Heart-lung machine consisted of a roller pump and a CML Duo (Cobe Cardiovascular Inc, Arvada, CO) membrane oxygenator. We used cold (8°C) blood cardioplegia administered antegrade into the aortic root and retrograde into the coronary sinus. Patients were not actively cooled, but "drifted" to a mean rectal temperature of 33.4°C and rewarmed to at least 37°C before coming off bypass.
Group B (41 patients) underwent operation on the beating heart without extracorporeal circulation. For anastomoses we used the CTS Retractor (Cardio Thoracic Systems Inc, Cupertino, CA) or the Medtronic Octopus II Retractor (Medtronic, DLP, Grand Rapids, MI).
Demographic variables and surgical details are listed in Table 1. All patients were extubated in the intensive care unit (ICU) only after being sufficiently awake, adequately warm, and in stable circulatory condition.
|
S100 probes were taken as listed in Table 2. All samples were immediately centrifuged and the sera deep frozen. The samples were then analyzed collectively after patient recruitment was finished.
|
| Results |
|---|
|
|
|---|
Surgical complications consisted of two nonfatal myocardial infarctions in group A, one wound infection in group A, and one postoperative bleeding in group B requiring resternotomy. No patient needed an intraaortic balloon pump or other mechanical assist in either group. There was no autotransfusion of shed blood after the end of the operation.
S100 levels (Fig 1) were nearly identical in both groups at the beginning of the operation (no. 1). In off-pump patients (group B), S100 concentration increased slightly with a flat "peak" at the time of ICU admission (no. 4) and then quickly dropped to preoperative levels.
|
|
| Comment |
|---|
|
|
|---|
As the incidence of stroke is low in coronary bypass operations, even when using extracorporeal circulation [1, 3, 11], large cohorts of patients would be necessary to prove any statistical difference between on-pump and off-pump techniques. Neurocognitive deficits are even harder to evaluate and results differ widely [3, 5] according to patient numbers and test methods.
Since the discovery of S100 protein as a marker for cerebral damage it has been used in neurologic and trauma patients [7] to prove organic cerebral damage. A number of studies have shown elevated S100 levels also in patients undergoing cardiac operations using extracorporeal circulation [8, 1215]. Other investigators, such as Kumar and coworkers [16] and Taggart and colleagues [17], have also described S100 release during and after extracorporeal circulation in neurologic asymptomatic patients. These findings suggest impairment of the blood-brain barrier and cerebral cell injury even in the absence of neurologic symptoms. Our own data confirm the adverse side effects of extracorporeal circulation, showing a fourfold increase of serum S100 levels immediately after the onset of cardiopulmonary bypass and a return to baseline levels only 6 hours after decannulation. In the off-pump group, however, S100 levels remained nearly normal, suggesting a more physiologic course of the operation, at least where the brain is concerned.
As the incidence of manifest neurologic deficits or severe psychologic deterioration is rare in routine coronary bypass operations, we are not sure whether these results will have any clinical impact. In our trial there was no neurologic deficit in either group. Further studies, including large cohorts of patients, are necessary to answer this question. Considering increasing age and comorbidity of cardiac patients, we think that less invasive techniques will be of utmost importance in the future.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. H. Moller, L. Penninga, J. Wetterslev, D. A. Steinbruchel, and C. Gluud Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses Eur. Heart J., November 1, 2008; 29(21): 2601 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Raja and G. D Dreyfus Current Status of Off-pump Coronary Artery Bypass Surgery Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 164 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Dewey and M. J. Mack Myocardial Revascularization without Cardiopulmonary Bypass Card. Surg. Adult, January 1, 2008; 3(2008): 633 - 654. [Full Text] |
||||
![]() |
A. Sedrakyan, A. W. Wu, A. Parashar, E. B. Bass, and T. Treasure Off-Pump Surgery Is Associated With Reduced Occurrence of Stroke and Other Morbidity as Compared With Traditional Coronary Artery Bypass Grafting: A Meta-Analysis of Systematically Reviewed Trials * Supplemental Appendix I Stroke, November 1, 2006; 37(11): 2759 - 2769. [Full Text] [PDF] |
||||
![]() |
D. N. Wijeysundera, W. S. Beattie, G. Djaiani, V. Rao, M. A. Borger, K. Karkouti, and R. J. Cusimano Off-Pump Coronary Artery Surgery for Reducing Mortality and Morbidity: Meta-Analysis of Randomized and Observational Studies J. Am. Coll. Cardiol., September 6, 2005; 46(5): 872 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Diephuis, K. G. M. Moons, A. N. Nierich, M. Bruens, D. van Dijk, and C. J. Kalkman Jugular bulb desaturation during coronary artery surgery: a comparison of off-pump and on-pump procedures Br. J. Anaesth., June 1, 2005; 94(6): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bainbridge, J. Martin, and D. Cheng Off Pump Coronary Artery Bypass Graft Surgery Versus Conventional Coronary Artery Bypass Graft Surgery: A Systematic Review of the Literature Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 105 - 111. [Abstract] [PDF] |
||||
![]() |
G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J.M.G. van der Heijden, H. M. Nathoe, E. W.L. Jansen, and D. E. Grobbee Meta-analysis on the effect of off-pump coronary bypass surgery Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 81 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Reston, S. J. Tregear, and C. M. Turkelson Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting Ann. Thorac. Surg., November 1, 2003; 76(5): 1510 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parolari, F. Alamanni, A. Cannata, M. Naliato, L. Bonati, P. Rubini, F. Veglia, E. Tremoli, and P. Biglioli Off-pump versus on-pump coronary artery bypass: meta-analysis of currently available randomized trials Ann. Thorac. Surg., July 1, 2003; 76(1): 37 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzone, J. Gianetti, E. Picano, S. Bevilacqua, G. Zucchelli, A. Biagini, and M. Glauber Correlation between inflammatory response and markers of neuronal damage in coronary revascularization with and without cardiopulmonary bypass Perfusion, January 1, 2003; 18(1): 3 - 8. [Abstract] [PDF] |
||||
![]() |
Y. Fromes, D. Gaillard, O. Ponzio, M. Chauffert, M.-F. Gerhardt, P. Deleuze, and O. M. Bical Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Sabik, A. M. Gillinov, E. H. Blackstone, C. Vacha, P. L. Houghtaling, J. Navia, N. G. Smedira, P. M. McCarthy, D. M. Cosgrove, and B. W. Lytle Does off-pump coronary surgery reduce morbidity and mortality? J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche The systemic factor: the comparative roles of cardiopulmonary bypass and off-pump surgery in the genesis of patient injury during and following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos Systemic inflammation and cardiac surgery: an update Perfusion, September 1, 2001; 16(5): 353 - 360. [Abstract] [PDF] |
||||
![]() |
N. E. Khan, A. C. De Souza, and J. R. Pepper S100 protein: its use as a marker of cerebral damage in cardiac operations Ann. Thorac. Surg., August 1, 2001; 72(2): 666 - 667. [Full Text] [PDF] |
||||
![]() |
D. Whitaker S100 release as an indicator of cerebral damage Ann. Thorac. Surg., June 1, 2001; 71(6): 2085 - 2085. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |